GlassScriptPhysician profile
Larry D Stark
NPI 1205842291
$194.19
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.28 · 2020: $14.30 · 2021: $96.61.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $42.70 | 2019-2021 | |
| Dexcom, INC. | $23.68 | 2021 | |
| Astellas Pharma US INC | $21.04 | 2019 | |
| Amgen INC. | $17.88 | 2019 | |
| Amarin Pharma, INC. | $15.95 | 2019 | |
| Optos, INC. | $15.92 | 2021 | |
| Virtus Pharmaceuticals LLC | $14.74 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.62 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.60 | 2021 | |
| Abbvie INC. | $13.06 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Stark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.